Year: 2021

LivaNova to Present Scientific Data on VNS Therapy for Difficult-to-Treat Depression at 4th International Brain Stimulation Conference

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the 4th International Brain...

Remote Designed and Built Secure I.T. Environments ModCel Containerised Data Centre Installed for Norfolk & Norwich University Hospital NHS Foundation Trust

Unique design and build process during the Covid-19 pandemic meant the ModCel containers were only viewed in-person on installation and...

Abivax’s Phase 1/2 Clinical Study Results of ABX196 in Liver Cancer Show Good Tolerability and Promising Signals of Clinical Benefit and were Selected for Presentation at the ASCO GI Cancers Symposium 2022

ABX196 is Abivax's second compound in clinical development after lead drug-candidate ABX464ABX196 was well tolerated and demonstrated promising signals of...

error: Content is protected !!